NO990667D0 - Depeptid-benzamidin som kinogenase-inhibitor - Google Patents
Depeptid-benzamidin som kinogenase-inhibitorInfo
- Publication number
- NO990667D0 NO990667D0 NO990667A NO990667A NO990667D0 NO 990667 D0 NO990667 D0 NO 990667D0 NO 990667 A NO990667 A NO 990667A NO 990667 A NO990667 A NO 990667A NO 990667 D0 NO990667 D0 NO 990667D0
- Authority
- NO
- Norway
- Prior art keywords
- kinogenase
- depeptide
- benzamidine
- inhibitor
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19632772A DE19632772A1 (de) | 1996-08-14 | 1996-08-14 | Neue Benzamidine |
PCT/EP1997/004105 WO1998006740A1 (de) | 1996-08-14 | 1997-07-29 | Dipeptidische benzamidine als kininogenasen-inhibitoren |
Publications (2)
Publication Number | Publication Date |
---|---|
NO990667D0 true NO990667D0 (no) | 1999-02-12 |
NO990667L NO990667L (no) | 1999-04-12 |
Family
ID=7802623
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO990667A NO990667L (no) | 1996-08-14 | 1999-02-12 | Depeptid-benzamidin som kinogenase-inhibitor |
Country Status (18)
Country | Link |
---|---|
US (1) | US6440937B1 (no) |
EP (1) | EP0918792B1 (no) |
JP (1) | JP2000517300A (no) |
KR (1) | KR20000030004A (no) |
CN (1) | CN1233256A (no) |
AT (1) | ATE196637T1 (no) |
AU (1) | AU717692B2 (no) |
BR (1) | BR9711134A (no) |
CA (1) | CA2263344A1 (no) |
CZ (1) | CZ31199A3 (no) |
DE (2) | DE19632772A1 (no) |
ES (1) | ES2151741T3 (no) |
HU (1) | HUP0001796A3 (no) |
IL (1) | IL128231A0 (no) |
NO (1) | NO990667L (no) |
TW (1) | TW442471B (no) |
WO (1) | WO1998006740A1 (no) |
ZA (1) | ZA977240B (no) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9602263D0 (sv) | 1996-06-07 | 1996-06-07 | Astra Ab | New amino acid derivatives |
SE9602646D0 (sv) | 1996-07-04 | 1996-07-04 | Astra Ab | Pharmaceutically-useful compounds |
DE19632773A1 (de) * | 1996-08-14 | 1998-02-19 | Basf Ag | Neue Thrombininhibitoren |
AR013084A1 (es) | 1997-06-19 | 2000-12-13 | Astrazeneca Ab | Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados |
SE9704543D0 (sv) | 1997-12-05 | 1997-12-05 | Astra Ab | New compounds |
CA2334476A1 (en) | 1998-06-08 | 1999-12-16 | Ajinomoto Co., Inc. | Benzamidine derivative |
SE9804313D0 (sv) | 1998-12-14 | 1998-12-14 | Astra Ab | New compounds |
DE60037183T2 (de) | 1999-01-13 | 2008-10-09 | Astrazeneca Ab | Neue amidinbenzylamin-derivate und ihre verwendung als thrombin-inhibitoren |
WO2000061608A2 (de) * | 1999-04-09 | 2000-10-19 | Basf Aktiengesellschaft | Niedermolekulare inhibitoren von komplementproteasen |
AR023510A1 (es) | 1999-04-21 | 2002-09-04 | Astrazeneca Ab | Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina. |
SE0001803D0 (sv) | 2000-05-16 | 2000-05-16 | Astrazeneca Ab | New compounds i |
US6433186B1 (en) | 2000-08-16 | 2002-08-13 | Astrazeneca Ab | Amidino derivatives and their use as thormbin inhibitors |
DE10049937A1 (de) * | 2000-10-06 | 2002-04-11 | Knoll Ag | Niedermolekulare Inhibitoren von Serinproteasen mit Polyhydroxyalkyl- und Polyhydroxycycloalkylresten |
AR035216A1 (es) * | 2000-12-01 | 2004-05-05 | Astrazeneca Ab | Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios |
US7129233B2 (en) | 2000-12-01 | 2006-10-31 | Astrazeneca Ab | Mandelic acid derivatives and their use as thrombin inhibitors |
DE10064797A1 (de) * | 2000-12-22 | 2002-06-27 | Knoll Ag | Orale und parenterale pharmazeutische Formulierung, umfassend eine niedermolekulare Thrombininhibitor-Pro-Pharmakon |
DE10117730A1 (de) | 2001-04-09 | 2002-10-10 | Basf Ag | Umsetzung von (Di)Aminen in Gegenwart einer Lysinoxidase und eines Reduktionsmittels |
AR034517A1 (es) * | 2001-06-21 | 2004-02-25 | Astrazeneca Ab | Formulacion farmaceutica |
SE0201659D0 (sv) * | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | Modified release pharmaceutical formulation |
SE0201661D0 (sv) * | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | New salts |
US6849084B2 (en) * | 2002-12-31 | 2005-02-01 | Intek Technology L.L.C. | Stent delivery system |
US7781424B2 (en) * | 2003-05-27 | 2010-08-24 | Astrazeneca Ab | Modified release pharmaceutical formulation |
WO2005095327A1 (ja) | 2004-03-31 | 2005-10-13 | Ajinomoto Co., Inc. | アニリン誘導体 |
US7524354B2 (en) * | 2005-07-07 | 2009-04-28 | Research Foundation Of State University Of New York | Controlled synthesis of highly monodispersed gold nanoparticles |
TW200827336A (en) * | 2006-12-06 | 2008-07-01 | Astrazeneca Ab | New crystalline forms |
US20090061000A1 (en) * | 2007-08-31 | 2009-03-05 | Astrazeneca Ab | Pharmaceutical formulation use 030 |
PT3459564T (pt) | 2010-01-06 | 2022-01-31 | Takeda Pharmaceuticals Co | Proteínas de ligação à calicreína plasmática |
KR102320178B1 (ko) * | 2011-01-06 | 2021-11-02 | 다케다 파머수티컬 컴패니 리미티드 | 혈장 칼리크레인 결합 단백질 |
JP2016513682A (ja) | 2013-03-15 | 2016-05-16 | ダイアックス コーポレーション | 抗血漿カリクレイン抗体 |
PL3096798T3 (pl) | 2014-01-21 | 2021-07-26 | Takeda Pharmaceutical Company Limited | Białka wiążące kalikreinę osocza i ich zastosowanie w leczeniu obrzęku naczynioruchowego |
IL295414A (en) | 2014-03-27 | 2022-10-01 | Takeda Pharmaceuticals Co | Compositions and methods for treating macular edema as a result of diabetes |
US11286307B2 (en) | 2015-12-11 | 2022-03-29 | Takeda Pharmaceutical Company Limited | Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU675981B2 (en) | 1992-12-02 | 1997-02-27 | Bristol-Myers Squibb Company | Guanidinyl-substituted heterocyclic thrombin inhibitors |
SE9301916D0 (sv) | 1993-06-03 | 1993-06-03 | Ab Astra | New peptides derivatives |
ZA951617B (en) | 1994-03-04 | 1997-02-27 | Lilly Co Eli | Antithrombotic agents. |
DE4421052A1 (de) | 1994-06-17 | 1995-12-21 | Basf Ag | Neue Thrombininhibitoren, ihre Herstellung und Verwendung |
KR100388185B1 (ko) | 1995-02-17 | 2003-11-28 | 애보트 게엠베하 운트 콤파니 카게 | 트롬빈 억제제로서의 신규 디펩티드 아미딘 |
DE19632773A1 (de) | 1996-08-14 | 1998-02-19 | Basf Ag | Neue Thrombininhibitoren |
-
1996
- 1996-08-14 DE DE19632772A patent/DE19632772A1/de not_active Withdrawn
-
1997
- 1997-07-29 DE DE59702414T patent/DE59702414D1/de not_active Expired - Fee Related
- 1997-07-29 IL IL12823197A patent/IL128231A0/xx unknown
- 1997-07-29 WO PCT/EP1997/004105 patent/WO1998006740A1/de not_active Application Discontinuation
- 1997-07-29 CN CN97198721A patent/CN1233256A/zh active Pending
- 1997-07-29 EP EP97934552A patent/EP0918792B1/de not_active Expired - Lifetime
- 1997-07-29 BR BR9711134A patent/BR9711134A/pt not_active IP Right Cessation
- 1997-07-29 ES ES97934552T patent/ES2151741T3/es not_active Expired - Lifetime
- 1997-07-29 JP JP10509341A patent/JP2000517300A/ja active Pending
- 1997-07-29 HU HU0001796A patent/HUP0001796A3/hu unknown
- 1997-07-29 KR KR1019997001284A patent/KR20000030004A/ko not_active Application Discontinuation
- 1997-07-29 US US09/242,126 patent/US6440937B1/en not_active Expired - Fee Related
- 1997-07-29 CA CA002263344A patent/CA2263344A1/en not_active Abandoned
- 1997-07-29 AU AU37715/97A patent/AU717692B2/en not_active Ceased
- 1997-07-29 AT AT97934552T patent/ATE196637T1/de not_active IP Right Cessation
- 1997-07-29 CZ CZ99311A patent/CZ31199A3/cs unknown
- 1997-08-08 TW TW086111384A patent/TW442471B/zh active
- 1997-08-13 ZA ZA977240A patent/ZA977240B/xx unknown
-
1999
- 1999-02-12 NO NO990667A patent/NO990667L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP0001796A3 (en) | 2001-12-28 |
EP0918792B1 (de) | 2000-09-27 |
CA2263344A1 (en) | 1998-02-19 |
JP2000517300A (ja) | 2000-12-26 |
AU3771597A (en) | 1998-03-06 |
CZ31199A3 (cs) | 1999-06-16 |
WO1998006740A1 (de) | 1998-02-19 |
DE19632772A1 (de) | 1998-02-19 |
ES2151741T3 (es) | 2001-01-01 |
EP0918792A1 (de) | 1999-06-02 |
IL128231A0 (en) | 1999-11-30 |
AU717692B2 (en) | 2000-03-30 |
TW442471B (en) | 2001-06-23 |
US6440937B1 (en) | 2002-08-27 |
KR20000030004A (ko) | 2000-05-25 |
ZA977240B (en) | 1999-02-15 |
CN1233256A (zh) | 1999-10-27 |
NO990667L (no) | 1999-04-12 |
HUP0001796A2 (hu) | 2000-11-28 |
ATE196637T1 (de) | 2000-10-15 |
BR9711134A (pt) | 1999-08-17 |
DE59702414D1 (de) | 2000-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO990667D0 (no) | Depeptid-benzamidin som kinogenase-inhibitor | |
NO992492L (no) | Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer | |
ATE233274T1 (de) | Oxyiminopregnancarbolactone | |
AU5554198A (en) | 3-thiocarbamoylpyrazole derivatives as pesticides | |
AU6613896A (en) | Chemical compounds | |
MY125359A (en) | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods. | |
AU2787595A (en) | Novel thrombin inhibitors, the preparation and use thereof | |
BG103310A (en) | Benzonaphthyridins as bronchial therapeutical means | |
TR200800474T2 (tr) | Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem. | |
BG103399A (en) | New heterocycle-substituted benzamides and their application for the treatment of diseases | |
AU2001266575A1 (en) | Chemical compounds | |
TR200201128T2 (tr) | PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri. | |
NO981393D0 (no) | Guanidinoproteasehemmere | |
AU7027100A (en) | Novel compounds | |
AU1192397A (en) | Substituted thiazolines and their use for controlling animal pests | |
AU2002211493A1 (en) | Indole derivatives as pde5-inhibitors | |
NZ336091A (en) | Aqueous disinfecting cleaning composition | |
ATE330958T1 (de) | Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate | |
PT1104419E (pt) | Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao | |
AU6722498A (en) | Disubstituted biphenyloxazolines | |
MY133139A (en) | N-substituted azabicycloheptane derivatives, their preparation and use | |
DE59905355D1 (de) | Verwendung von katecholderivaten als proteinaseinhibitoren | |
AP2001002047A0 (en) | Isoquinoliness as urokinase inhibitors. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |